Filter
75
Text search:
reporting
ADRs
Featured
Recommendations
6
New Publications
28
Language
Document type
No document type
47
Guidelines
11
Studies & Reports
9
Manuals
2
Strategic & Response Plan
2
Training Material
1
Brochures
1
Situation Updates
1
Fact sheets
1
Countries / Regions
Ethiopia
6
Philippines
5
Kenya
5
Uganda
4
Nigeria
3
Ghana
3
India
3
Nepal
3
South Africa
3
Malawi
3
Namibia
3
Sierra Leone
2
Rwanda
2
Bangladesh
2
Botswana
2
Lesotho
2
Zimbabwe
1
Zambia
1
Tanzania
1
Cambodia
1
Thailand
1
Gambia
1
Indonesia
1
South–East Asia Region
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
51
Capacity Building
1
Public Health
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
Pharmacy
15
TB
9
AMR
2
COVID-19
2
HIV
1
Mental Health
1
Caregiver
1
NTDs
1
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Therapeutics Information and Pharmacovigilance Centre | TIPC
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Accessed November, 2017
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
